RARRES2 and metabolic syndrome: Chemerin, a chemoattractant ligand for CMKLR13, 6, has been identified as a novel adipokine associated with obesity and metabolic syndrome and has been shown to promote adipogenesis and regulate glucose metabolism3, 4, 7, 8.